ÂÜÀòÂÒÂ×

Raphaël Canadas is a co-founder and managing partner at LandraTech since November 2020 and previously served as chief scientific officer at Tech4MED until February 2024. Canadas has extensive research experience, including a position as a visiting scientist at Universiteit Twente in 2021 and a postdoctoral researcher at Universidade do Minho from 2012 to 2020, focusing on bioprinting for liver implants and advanced cell culture systems. Educational credentials include a PhD in Tissue Engineering, Regenerative Medicine & Stem Cells from Universidade do Minho, an MS in Bioengineering and Nanosystems from Instituto Superior Técnico, and a BS in Cellular and Molecular Biology from Faculdade de Ciências e Tecnologia da Universidade NOVA de Lisboa.